Related Experiment Videos
Therapeutic approaches to Alzheimer's disease
1Elan Pharmaceuticals, South San Francisco, CA 94080, USA. ethorsett@elanpharma.com
Current Opinion in Chemical Biology
|August 26, 2000
Abstract:
Several recent advances have provided new insights and possibilities in defining therapeutic targets for Alzheimer's disease. Of particular importance is the identification of the beta-secretase enzyme and the demonstration that immunization of a transgenic mouse model of Alzheimer's disease with Abeta(1-42) peptide can prevent or alleviate neuropathological features of the disease.